A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03

Romidepsin, a potent histone deacetylase inhibitor, has shown activity in preclinical glioma models. The primary objectives of this trial were to determine the pharmacokinetics of romidepsin in patients with recurrent glioma on enzyme-inducing antiepileptic drugs (EIAEDs) and to evaluate the antitum...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Iwamoto, Fabio M., Lamborn, Kathleen R., Kuhn, John G., Wen, Patrick Y., Alfred Yung, W.K., Gilbert, Mark R., Chang, Susan M., Lieberman, Frank S., Prados, Michael D., Fine, Howard A.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2011
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3093337/
https://ncbi.nlm.nih.gov/pubmed/21377994
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nor017
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados